In summary, we proposed a novel prognostic nomogram model based on peripheral blood biomarkers and emphasized their importance as potential prognostic biomarkers for the treatment of NPC with anti-PD-1/PD-L1. This evidence concerns the gene CD274 and nasopharyngeal carcinoma.